Form 4: STERIS plc Executive Acquires Shares and Options

John Adam Zangerle, a Senior VP at STERIS plc, acquired shares and options in the company on June 4, 2024.

Summary

• On June 4, 2024, John Adam Zangerle, a Senior VP, General Counsel, and Secretary at STERIS plc, acquired 4,128 ordinary shares at $0.
• Following the transaction, Zangerle directly owns 33,342 ordinary shares, including 9,357 restricted shares that will vest over the next few years.
• Zangerle also acquired an option to buy 15,684 ordinary shares at an exercise price of $251.34, which becomes exercisable in installments starting June 4, 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of executive stock transactions. The acquisition of shares and options by an executive is generally viewed as a positive sign, but it's not a major event.

Positives

• The acquisition of shares and options by a high-ranking executive could be seen as a positive signal, indicating confidence in the company's future performance.

Industry Context

Executive stock ownership is a common practice in publicly traded companies like STERIS plc to align management's interests with those of shareholders.

Comparison to Industry Standards

• Executive compensation packages, including stock options and restricted shares, are standard practice among STERIS plc's peers in the medical device and equipment industry.
• Companies like Medtronic, Stryker, and Boston Scientific also utilize similar equity-based compensation to incentivize their executives.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a key executive.

Key Dates